Miles Stanford

Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17

R. Moots, W. Lynn, S. Lightman, 2014, Annals of the rheumatic diseases.